(Q44060319)

English

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anne-Marie Mes-Masson

4

1 reference

Europe PubMed Central

29 November 2017

author name string

Emily N Manderson

1

1 reference

Europe PubMed Central

29 November 2017

Nadège Presneau

2

1 reference

Europe PubMed Central

29 November 2017

Diane Provencher

3

1 reference

Europe PubMed Central

29 November 2017

Patricia N Tonin

5

1 reference

Europe PubMed Central

29 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

29 November 2017

Molecular Carcinogenesis

1 reference

Europe PubMed Central

29 November 2017

34

1 reference

Europe PubMed Central

29 November 2017

78-90

1 reference

Europe PubMed Central

29 November 2017

2

1 reference

Europe PubMed Central

29 November 2017

Mapping of chromosome 3p deletions in human epithelial ovarian tumors.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Potential role of the inactivated X chromosome in ovarian epithelial tumor development.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

In search of the tumour-suppressor functions of BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

BRCA1 and cell signaling

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

A somatic BRCA1 mutation in an ovarian tumour.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Cytogenetic studies in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Chromosome aberrations in 35 primary ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Chromosome abnormalities in primary endometrioid ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID mice

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Allelic loss in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Loss of markers linked to BRCA1 precedes loss at important cell cycle regulatory genes in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Whole chromosome 17 loss in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Genomic deletion and p53 inactivation in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Mutation, ageing, and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Age contrast in ovarian pathology.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FMC.10051

21 January 2018

Identifiers

10.1002/MC.10051

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44060319&oldid=2106131523"